mRNA |
piperlongumine:MST-312 (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.067 |
0.05 |
mRNA |
ceranib-2 |
CTRPv2 |
pan-cancer |
AAC |
-0.062 |
0.05 |
mRNA |
MK 1775 |
CTRPv2 |
pan-cancer |
AAC |
-0.064 |
0.05 |
mRNA |
PF-184 |
CTRPv2 |
pan-cancer |
AAC |
-0.062 |
0.06 |
mRNA |
NVP-ADW742 |
CTRPv2 |
pan-cancer |
AAC |
-0.065 |
0.06 |
mRNA |
BRD9876:MK-1775 (4:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.22 |
0.06 |
mRNA |
sirolimus:bortezomib (250:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.062 |
0.06 |
mRNA |
selumetinib:piperlongumine (8:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.065 |
0.06 |
mRNA |
968 |
CTRPv2 |
pan-cancer |
AAC |
-0.13 |
0.06 |
mRNA |
selumetinib:tretinoin (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.064 |
0.06 |